<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">respiratory </span>
   <span class="font19">patients </span>
   <span class="font18">viral </span>
   <span class="font18">infection </span>
   <span class="font17">HCT </span>
   <span class="font17">transplant </span>
   <span class="font17">RSV </span>
   <span class="font17">tract </span>
   <span class="font17">immunocompromised </span>
   <span class="font16">lower </span>
   <span class="font16">ribavirin </span>
   <span class="font16">influenza </span>
   <span class="font16">virus </span>
   <span class="font15">cell </span>
   <span class="font15">associated </span>
   <span class="font14">hematopoietic </span>
   <span class="font14">infections </span>
   <span class="font14">recipients </span>
   <span class="font14">children </span>
   <span class="font14">disease </span>
   <span class="font14">human </span>
   <span class="font14">viruses </span>
   <span class="font14">detection </span>
   <span class="font14">PIV </span>
   <span class="font14">clinical </span>
   <span class="font14">treatment </span>
   <span class="font13">pediatric </span>
   <span class="font13">{border-style </span>
   <span class="font13">Infect </span>
   <span class="font13">px;} </span>
   <span class="font13">â€¢Isolation </span>
   <span class="font13">#ffffff;} </span>
   <span class="font13">Dis </span>
   <span class="font13">available </span>
   <span class="font13">risk </span>
   <span class="font12">HMPV </span>
   <span class="font12">care </span>
   <span class="font12">months </span>
   <span class="font12">including </span>
   <span class="font12">syncytial </span>
   <span class="font12">use </span>
   <span class="font12">PIV- </span>
   <span class="font12">Transplant </span>
   <span class="font12">oral </span>
   <span class="font12">recipients, </span>
   <span class="font12">severe </span>
   <span class="font12">therapy </span>
   <span class="font12">vaccination </span>
   <span class="font12">adults </span>
   <span class="font12">common </span>
   <span class="font12">detected </span>
   <span class="font12">patients. </span>
   <span class="font12">RSV, </span>
   <span class="font12">SOT </span>
   <span class="font12">adult </span>
   <span class="font12">antiviral </span>
   <span class="font12">influenza, </span>
   <span class="font12">patients, </span>
   <span class="font12">recommended </span>
   <span class="font12">aerosolized </span>
   <span class="font12">organ </span>
   <span class="font12">progression </span>
   <span class="font12">studies </span>
   <span class="font11">allogeneic </span>
   <span class="font11">control </span>
   <span class="font11">high </span>
   <span class="font11">mortality </span>
   <span class="font11">oseltamivir </span>
   <span class="font11">outcomes </span>
   <span class="font11">recipients. </span>
   <span class="font11">recipients: </span>
   <span class="font11">HMPV, </span>
   <span class="font11">HRV </span>
   <span class="font11">PIV, </span>
   <span class="font11">Respiratory </span>
   <span class="font11">data </span>
   <span class="font11">factors </span>
   <span class="font11">multicenter </span>
   <span class="font11">retrospective </span>
   <span class="font11">similar </span>
   <span class="font11">solid </span>
   <span class="font11">used </span>
   <span class="font11">vaccine </span>
   <span class="font11">zanamivir </span>
   <span class="font11">Influenza </span>
   <span class="font11">Marrow </span>
   <span class="font11">hospitalized </span>
   <span class="font11">lung </span>
   <span class="font11">nasal </span>
   <span class="font11">parainfluenza </span>
   <span class="font11">potential </span>
   <span class="font11">prolonged </span>
   <span class="font11">px; </span>
   <span class="font11">{font-family </span>
   <span class="font11">Pediatric </span>
   <span class="font11">antibody </span>
   <span class="font11">children. </span>
   <span class="font11">demonstrated </span>
   <span class="font11">efficacy </span>
   <span class="font11">font-size </span>
   <span class="font11">guidelines </span>
   <span class="font11">hematologic </span>
   <span class="font11">include </span>
   <span class="font11">intensive </span>
   <span class="font11">large </span>
   <span class="font11">molecular </span>
   <span class="font11">peramivir </span>
   <span class="font11">present </span>
   <span class="font11">procedures </span>
   <span class="font11">severely </span>
   <span class="font11">shedding </span>
   <span class="font11">significant </span>
   <span class="font11">stem </span>
   <span class="font11">study </span>
   <span class="font11">symptoms </span>
   <span class="font11">young </span>
   <span class="font11">HCT, </span>
   <span class="font11">HCoV, </span>
   <span class="font11">Oncology </span>
   <span class="font11">United </span>
   <span class="font11">antibodies </span>
   <span class="font11">availability </span>
   <span class="font11">chemotherapy </span>
   <span class="font11">community </span>
   <span class="font11">considered </span>
   <span class="font11">contact </span>
   <span class="font11">days </span>
   <span class="font11">decreased </span>
   <span class="font11">double; </span>
   <span class="font11">evaluated </span>
   <span class="font11">evidence </span>
   <span class="font11">fever </span>
   <span class="font11">hosts </span>
   <span class="font11">however, </span>
   <span class="font11">infection. </span>
   <span class="font11">likely </span>
   <span class="font11">oncology </span>
   <span class="font11">outbreaks </span>
   <span class="font11">sensitive </span>
   <span class="font11">strains </span>
   <span class="font11">upper </span>
   <span class="font11">virus, </span>
   <span class="font11">â€¢Infection </span>
   <span class="font11">â€¢Supportive </span>
   <span class="font10">Blood </span>
   <span class="font10">Elsevier </span>
   <span class="font10">Infections </span>
   <span class="font10">Infectious </span>
   <span class="font10">Limited </span>
   <span class="font10">asymptomatic </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">bronchoalveolar </span>
   <span class="font10">caused </span>
   <span class="font10">diagnosis </span>
   <span class="font10">disease, </span>
   <span class="font10">drug </span>
   <span class="font10">effect </span>
   <span class="font10">generally </span>
   <span class="font10">high-dose </span>
   <span class="font10">hospital </span>
   <span class="font10">immune </span>
   <span class="font10">immunosuppressed </span>
   <span class="font10">inpatient </span>
   <span class="font10">leukemia </span>
   <span class="font10">metapneumovirus </span>
   <span class="font10">need </span>
   <span class="font10">outbreak </span>
   <span class="font10">outpatient </span>
   <span class="font10">oxygen </span>
   <span class="font10">pneumonia </span>
   <span class="font10">prophylaxis </span>
   <span class="font10">randomized </span>
   <span class="font10">rates </span>
   <span class="font10">receiving </span>
   <span class="font10">recent </span>
   <span class="font10">recommend </span>
   <span class="font10">regarding </span>
   <span class="font10">relatively </span>
   <span class="font10">remains </span>
   <span class="font10">resistance </span>
   <span class="font10">review </span>
   <span class="font10">rhinovirus </span>
   <span class="font10">solid; </span>
   <span class="font10">time </span>
   <span class="font10">transmission </span>
   <span class="font10">transplant, </span>
   <span class="font10">trial </span>
   <span class="font10">trials </span>
   <span class="font10">virus; </span>
   <span class="font10">viruses, </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">â€¢Consider </span>
   <span class="font10">â€¢Vaccination </span>
   <span class="font10">Available </span>
   <span class="font10">COVID- </span>
   <span class="font10">Clinical </span>
   <span class="font10">HCoVs </span>
   <span class="font10">HRV, </span>
   <span class="font10">New </span>
   <span class="font10">Nosocomial </span>
   <span class="font10">Ribavirin </span>
   <span class="font10">bold </span>
   <span class="font10">cancer </span>
   <span class="font10">centre </span>
   <span class="font10">close </span>
   <span class="font10">comparing </span>
   <span class="font10">concern </span>
   <span class="font10">consider </span>
   <span class="font10">courier; </span>
   <span class="font10">currently </span>
   <span class="font10">death. </span>
   <span class="font10">diagnostic </span>
   <span class="font10">em; </span>
   <span class="font10">epidemiology </span>
   <span class="font10">fatal </span>
   <span class="font10">followed </span>
   <span class="font10">health </span>
   <span class="font10">healthy </span>
   <span class="font10">high-risk </span>
   <span class="font10">impact </span>
   <span class="font10">infected </span>
   <span class="font10">infection, </span>
   <span class="font10">inhaled </span>
   <span class="font10">intravenous </span>
   <span class="font10">levels </span>
   <span class="font10">malignancy </span>
   <span class="font10">monoclonal </span>
   <span class="font10">morbidity </span>
   <span class="font10">mortality. </span>
   <span class="font10">novel </span>
   <span class="font10">older </span>
   <span class="font10">onset </span>
   <span class="font10">outcome </span>
   <span class="font10">particularly </span>
   <span class="font10">prevention </span>
   <span class="font10">prospective </span>
   <span class="font10">protein, </span>
   <span class="font10">pt;} </span>
   <span class="font10">quality </span>
   <span class="font10">reported </span>
   <span class="font10">require </span>
   <span class="font10">resource </span>
   <span class="font10">result </span>
   <span class="font10">results </span>
   <span class="font10">setting </span>
   <span class="font10">shedding, </span>
   <span class="font10">starting </span>
   <span class="font10">undergoing </span>
   <span class="font10">vaccines </span>
   <span class="font10">weeks </span>
   <span class="font10">younger </span>
  </p>
 </body>
</html>
